LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 62.66 771.67 4857 8978 0.5410 0.6814
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 62.66 771.67 4693 8978 0.5227 0.6651
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 62.66 771.67 5421 8978 0.6038 0.7344
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 64.88 771.67 4984 9447 0.5276 0.6756
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 64.88 771.67 4887 9447 0.5173 0.6666
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 64.88 771.67 5654 9447 0.5985 0.7352
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 67.10 771.67 5285 9800 0.5393 0.6900
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 67.10 771.67 5037 9800 0.5140 0.6680
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 67.10 771.67 5945 9800 0.6066 0.7451
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 69.32 771.67 5530 10212 0.5415 0.6964
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 69.32 771.67 5221 10212 0.5113 0.6705
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 69.32 771.67 6149 10212 0.6021 0.7454
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 71.54 771.67 5743 10532 0.5453 0.7028
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 71.54 771.67 5409 10532 0.5135 0.6760
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 71.54 771.67 6519 10532 0.6189 0.7611
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 73.76 771.67 5944 10851 0.5478 0.7080
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 73.76 771.67 5526 10851 0.5092 0.6756
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 73.76 771.67 6760 10851 0.6229 0.7666
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 76.02 771.67 6264 11106 0.5640 0.7234
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 76.02 771.67 5693 11106 0.5126 0.6811
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 76.02 771.67 7039 11106 0.6338 0.7764
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 78.25 771.67 6526 11367 0.5741 0.7335
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 78.25 771.67 5796 11367 0.5099 0.6813
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 78.25 771.67 7385 11367 0.6496 0.7896
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 80.48 771.67 6859 11685 0.5870 0.7459
MN20160304_L01
E20